Overview Of Endometrium cancer
Endometrial cancer, also known as uterine cancer, is a malignancy that originates in the lining of the uterus (endometrium). It is the most common gynecologic cancer in developed countries and primarily affects postmenopausal women, though it can occur in younger women. The most common type is endometrioid adenocarcinoma, which is often linked to excess estrogen exposure. Symptoms typically include abnormal vaginal bleeding, pelvic pain, and discharge. Early detection and treatment are crucial for improving survival rates, as endometrial cancer is often diagnosed at an early stage due to its noticeable symptoms. ---
Symptoms of Endometrium cancer
- The most common symptom of endometrial cancer is abnormal vaginal bleeding, such as bleeding after menopause or irregular periods in premenopausal women. Other symptoms may include pelvic pain, a feeling of fullness in the pelvis, and abnormal vaginal discharge. In advanced stages, symptoms may include weight loss, fatigue, and pain during intercourse. Early recognition of symptoms and prompt medical evaluation are crucial for timely diagnosis and treatment. ---
Causes of Endometrium cancer
- The exact cause of endometrial cancer is not fully understood, but several factors contribute to its development. Prolonged exposure to estrogen without the balancing effect of progesterone is a major risk factor. This can occur due to obesity, hormone replacement therapy (estrogen-only), or conditions like polycystic ovary syndrome (PCOS). Other risk factors include age (over 50), a history of endometrial hyperplasia, diabetes, and a family history of Lynch syndrome or other hereditary cancer syndromes. Understanding these causes helps in prevention and early detection. ---
Risk Factors of Endometrium cancer
- Several factors increase the risk of developing endometrial cancer. Obesity is a significant risk factor, as excess fat tissue increases estrogen levels. Hormonal imbalances, such as those caused by estrogen-only hormone therapy or PCOS, also elevate the risk. Age (over 50), a history of endometrial hyperplasia, and diabetes are additional risk factors. Genetic predisposition, such as Lynch syndrome or a family history of endometrial or colorectal cancer, increases susceptibility. Preventive measures, such as maintaining a healthy weight and managing hormonal imbalances, reduce the likelihood of endometrial cancer. ---
Prevention of Endometrium cancer
- Preventing endometrial cancer involves addressing modifiable risk factors. Maintaining a healthy weight through diet and exercise reduces estrogen levels and lowers the risk. Managing hormonal imbalances, such as those caused by PCOS or estrogen-only hormone therapy, is important. Regular screening for individuals with a family history of Lynch syndrome or other hereditary cancer syndromes can aid in early detection. Public health initiatives promoting healthy lifestyles and awareness of symptoms further reduce the incidence of endometrial cancer. ---
Prognosis of Endometrium cancer
- The prognosis for endometrial cancer is generally favorable, especially when diagnosed at an early stage. The five-year survival rate for localized endometrial cancer is over 90%. However, advanced-stage or high-grade cancers have a poorer prognosis, with five-year survival rates dropping significantly. Early detection through prompt evaluation of symptoms and adherence to treatment plans are critical for improving outcomes. Public health measures, such as promoting healthy lifestyles and awareness of symptoms, further enhance prognosis. ---
Complications of Endometrium cancer
- Endometrial cancer can lead to several complications, particularly in advanced stages. Metastasis to other organs, such as the lungs, liver, or bones, can cause organ-specific symptoms. Treatment side effects, such as lymphedema after lymph node dissection or menopausal symptoms after hysterectomy, may affect quality of life. Recurrence of cancer is a concern, especially in high-risk cases. Early intervention and supportive care are essential to prevent complications and improve quality of life. ---
Related Diseases of Endometrium cancer
- Endometrial cancer is closely related to other gynecologic cancers, such as ovarian or cervical cancer, which share similar risk factors and symptoms. It is also associated with conditions like endometrial hyperplasia, PCOS, and Lynch syndrome, which increase the risk of malignancy. Understanding these related diseases is important for comprehensive diagnosis and management. Preventive measures for endometrial cancer also reduce the risk of other gynecologic conditions. --- Let me know if you need further adjustments!
Treatment of Endometrium cancer
The treatment of endometrial cancer depends on the stage and grade of the cancer, as well as the patient’s overall health. Surgery, typically a hysterectomy with removal of the ovaries and fallopian tubes, is the primary treatment for early-stage endometrial cancer. Lymph node dissection may be performed to check for spread. Radiation therapy, chemotherapy, or hormone therapy may be used as adjuvant treatments for advanced or high-risk cases. Targeted therapies and immunotherapy are emerging options for specific types of endometrial cancer. Early and multidisciplinary treatment improves outcomes. ---
Generics For Endometrium cancer
Our administration and support staff all have exceptional people skills and trained to assist you with all medical enquiries.

Megestrol Acetate
Megestrol Acetate

Bevacizumab
Bevacizumab

Carboplatin
Carboplatin

Cisplatin
Cisplatin

Crystalline Mitomycin-C
Crystalline Mitomycin-C

Doxorubicin Hydrochloride
Doxorubicin Hydrochloride

Filgrastim
Filgrastim

Paclitaxel
Paclitaxel

Tamoxifen
Tamoxifen

Megestrol Acetate
Megestrol Acetate

Bevacizumab
Bevacizumab

Carboplatin
Carboplatin

Cisplatin
Cisplatin

Crystalline Mitomycin-C
Crystalline Mitomycin-C

Doxorubicin Hydrochloride
Doxorubicin Hydrochloride

Filgrastim
Filgrastim

Paclitaxel
Paclitaxel

Tamoxifen
Tamoxifen